BioNTech, Pfizer seek declaratory judgment against CureVac COVID-19 vaccine patent infringement claims
JURIST
JULY 26, 2022
The companies seek to quell claims by CureVac of intellectual property violations. The Pfizer-BioNTech vaccine, trademarked as COMIRNATY ®, was the first successful mRNA drug product approved in the United States and was expedited on an emergency basis by the Food and Drug Administration (FDA). ” .
Let's personalize your content